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Abstract
Background: One of the numerous challenges preterm birth poses for parents and physicians is prognostic
disclosure. Prognoses are based on scientific evidence and medical experience. They are subject to individual
assessment and will generally remain uncertain with regard to the individual. This can result in differences in
prognostic framing and thus affect the recipients’ perception. In neonatology, data on the effects of prognostic
framing are scarce. In particular, it is unclear whether parents prefer a more optimistic or a more pessimistic
prognostic framing.
Objective: To explore parents’ preferences concerning prognostic framing and its effects on parent-reported
outcomes and experiences. To identify predictors (demographic, psychological) of parents’ communication
preferences.
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Design, setting, participants: Unblinded, randomized controlled crossover trial (RCT) at the Division of
Neonatology of the University Medical Center Mainz, Germany, including German-speaking parents or guardians of
infants born preterm between 2010 and 2019 with a birth weight < 1500 g. Inclusion of up to 204 families is
planned, with possible revision according to a blinded sample size reassessment.
Intervention: Embedded in an online survey and in pre-specified order, participants will watch two video vignettes
depicting a more optimistic vs. a more pessimistic framing in prognostic disclosure to parents of a preterm infant.
Apart from prognostic framing, all other aspects of physician-parent communication are standardized in both
videos.
Main outcomes and measures: At baseline and after each video, participants complete a two-part online
questionnaire (baseline and post-intervention). Primary outcome is the preference for either a more optimistic or a
more pessimistic prognostic framing. Secondary outcomes include changes in state-anxiety (STAI-SKD), satisfaction
with prognostic framing, evaluation of prognosis, future optimism and hope, preparedness for shared decision-
making (each assessed using customized questions), and general impression (customized question), professionalism
(adapted from GMC Patient Questionnaire) and compassion (Physician Compassion Questionnaire) of the consulting
physician.
Discussion: This RCT will explore parents’ preferences concerning prognostic framing and its effects on physician-
parent communication. Results may contribute to a better understanding of parental needs in prognostic disclosure
and will be instrumental for a broad audience of clinicians, scientists, and ethicists.
Trial registration: German Clinical Trials Register DRKS00024466. Registered on April 16, 2021.
Keywords: Neonatal ICU, Physician-parent communication, Parent-centered communication, Parent-centered
research, Prognosis, Uncertainty, Message framing, Optimism, Pessimism
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Introduction
Background and rationale {6a}
The birth of a very low birth weight infant (VLBWI) is
associated with numerous challenges, even for
experienced neonatologists. This can be due to the
medical uncertainties, ethical controversy, and need for
timely interventions related thereto [2, 3]. In addition,
the setting of a neonatal intensive care unit (NICU)
places high demands on parents [3, 4]. Having recently
assumed their new role, they are expected to make vital
decisions on behalf of their newborn (so-called surrogate
decision-making), decisions that equally affect their own
future as well as that of their child. This is one of the
reasons why some parents describe the experience of
prematurity as one that can even be perceived as a life
transformation [3].
One challenge prematurity entails for physicians and
parents alike is the disclosure of prognoses, i.e.,
communicating uncertainty. As prognostic disclosure
enables the stakeholders to make realistic therapeutic
decisions that are appropriate to their situation (here: a
premature infant’s situation), it should be an integral
part of communication between physicians and patients
(here: parents) [5]. Prognoses, however, are based on
scientific knowledge (medical evidence) and medical
experience. They represent a statistical or frequency-
based statement about the probability of an illness tra-
jectory, are subject to individual assessment, and hence,
will always remain uncertain with regard to the individ-
ual. It can be assumed that it is a major challenge for
parents to cope with the uncertainty concerning the fu-
ture of their preterm infant and their family. For physi-
cians, on the other hand, prognoses entail the difficult
task to deduce a personal probability concerning the re-
spective premature infant’s future prospect from a fre-
quent probability [6]. Moreover, it is the physicians’
responsibility to communicate the respective prognosis
and the associated uncertainty to parents. In doing so,
physicians are expected to be realistic, i.e., neither too
optimistic nor too pessimistic.
In addition, previous studies have concluded that
prognostic disclosure should strike a balance between
providing a concrete prognosis through honesty and
communicating hope in a realistic way. Researchers
postulate that this can be achieved by imparting medical
empathy as well as by reassuring parents that they will
not be abandoned and that the attending physician is
available for queries [7, 8]. Consequently, successful
physician-parent communication not only requires med-
ical expertise, but also the physicians’ interpersonal com-
petence to perceive the needs and preferences of the
parents.
Studies in oncology have shown that physicians
initiate and proportionally dominate communication
regarding prognosis [9, 10]. Prognoses are mostly
communicated vaguely and with a focus on medical
facts that are difficult for laypersons to understand [9–
12]. This conflicts with the desire of parents of critically
ill children for a clear communication of a specific
prognosis as well as for explicit assertions concerning
the impact of the prognosis on their child’s quality of
life. This way of communication mainly succeeds when
communicating good news, whereas conveying
unfavorable prognoses is much more challenging [13].
Moreover, studies indicate that medical professionals
tend to be rather (overly) optimistic than pessimistic
when framing unfavorable prognoses [11, 12, 14].
Optimistic framing of bad news is often understood (by
physicians) as an attempt not to generate a sense of
hopelessness in patients (here: parents) [15, 16]. Hope,
however, is complex and multimodal [17]. Studies
indicate that despite an unfavorable prognosis, it is not
unrealistic for parents to hope for a certain outcome to
be achieved in their own child, even if they do not
expect, i.e., cannot be optimistic, that it will occur [18].
Parents can thus hope that in the individual case of their
child the personal probability of the occurrence of the
prognosis deviates from the frequent probability in the
positive sense for the health and quality of life of the
child, even if they are not optimistic in this respect.
Accordingly, it is possible for the consulting physician to
preserve parental hope regardless of a prognosis’
severity, however, dependent of the manner of
prognostic disclosure [18]. It is known that the realistic
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delineation of an unfavorable prognosis in its overall
severity does not contradict the communication of hope
[16, 19, 20]. In fact, honesty promotes a sense of hope as
it removes uncertainty and allows parents to make a
decision consistent with the child’s situation [21]. Data
from other medical disciplines suggest that optimistic
advice is initially preferred and experienced as positive,
and it also increases the perceived empathy of,
confidence in, and trustworthiness of medical staff [22].
Notwithstanding, (overly) optimistic framing can be
unbeneficial in other regards. It may hamper a realistic
assessment of the actual prognosis by parents and thus
may impede making an adequate therapeutic decision
[14]. Less optimistic framing, on the other hand, entails
greater concordance between medical professionals’ and
parents’ assessment of the severity of a prognosis and may
form the basis of more realistic therapeutic decisions [14].
Furthermore, particularly when a predicted outcome
occurs, less optimistic consultation appears to be more
beneficial with regard to the physician-parent relationship
as well as concerning parents’ coping with the condition
[16, 22]. On the contrary, less optimistic disclosure of in-
formation can also be experienced as negative, causing
distress and thus complicating communication between
the stakeholders [16].
Reviewing the partially contradictory scientific findings
from other disciplines, the question arises as to which
manner of communication, i.e.,framing, forms the basis
of successful communication in the context of a NICU.
In this regard, it is also of interest to take a closer look
at the parental perspective. It is known that parents
want to be asked how to receive information concerning
their child, and that the choice of words is important
[23]. In most cases, when parents express dissatisfaction
with their child’s NICU stay, their child is well cared for,
but their own parental needs, often in relation to
physician-parent communication, are not adequately ad-
dressed [24]. In neonatology, data concerning the fram-
ing of prognostic disclosure are scarce [9, 11]. Thus, it is
of scientific interest to explore parental preferences re-
garding prognostic framing and its effects.
Objectives and primary hypothesis {7}
 Primary objective is to determine whether a more
optimistic or a more pessimistic prognostic framing
is preferred by parents. The corresponding primary
hypothesis is that more parents prefer a more
pessimistic prognostic framing to a more optimistic
prognostic framing.
 Secondary objectives are to explore the effects of
prognostic framing (more optimistic vs. more
pessimistic) on parent-reported outcomes and expe-
riences, and to identify demographic and
psychological predictors of parental communication
preferences. All secondary hypotheses are listed
along with the respective outcomes in the “Out-
comes {12}” section. In addition, all secondary hy-
potheses are registered (in German and English) in
the German Clinical Trials Register (www.drks.de/
DRKS00024466) and can thus be viewed
transparently.
Trial design {8} and study setting (participating centers)
{9}
The COPE-Trial is an unblinded, randomized controlled
crossover trial (RCT). The parents’ survey is a single-
center study of the Division of Neonatology, Center for
Pediatric and Adolescent Medicine, University Medical
Center of the Johannes Gutenberg-University Mainz
(UMC Mainz). The COPE-Trial is conducted as an on-
line survey with two study groups. Concealed, stratified
randomization of participants to the study groups will
be performed in blocks of variable length. The online
survey consists of a two-part questionnaire (baseline and
post-intervention). Embedded in the post-intervention
questionnaire and in pre-specified order depending on
randomized group allocation, participants will watch two
video vignettes (video A and B) depicting a more opti-
mistic vs. a more pessimistic framing in prognostic dis-
closure to parents of a preterm infant. At baseline (data
acquisition t0) and after each video (outcome measure-
ment including data acquisition t1, t2, tend) participants
of both groups complete an identical set of questions.
Figure 1 in the “participant timeline {13}” section pro-
vides an overview of the study sequence and illustrates
the dependence of the sequence of the videos (AB vs.
BA) on randomization. Primary outcome is the partici-
pants’ preference for either a more optimistic or a more
pessimistic framing assessed by the parents’ preference
for one of the videos (A or B).
Methods: participants, interventions, and
outcomes
This document is based on the SPIRIT guidelines [1]. The
numbers in curly brackets in this protocol refer to SPIRIT
checklist item numbers. A completed SPIRIT checklist is




 Non-bereaved parents or guardians of infants born
preterm after December 31st, 2009, but before
January 1, 2020, with a VLBW < 1500 g, and
postnatal treatment at the UMC Mainz
 Informed (electronic) consent
Forth et al. Trials          (2021) 22:884 Page 4 of 21
Fig. 1 Study sequence and participant timeline, respectively
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 Self-reported sufficient proficiency of German
language
Exclusion criteria
 Self-reported acute, severe psychiatric condition
Consent provisions {26a, 26b}
Please see the “Ethics and dissemination” section.
Interventions
Description of study intervention(s) {11a}
Embedded in an online survey, participants will be exposed
to two video vignettes produced specifically for the COPE-
Trial. The scripted video vignettes (video A and B) depict a
fictional medical consultation between a physician and the
parents of a preterm infant. Purpose of the consultation is
the disclosure of an unfavorable prognosis on the occasion
of a severe intraventricular hemorrhage with parenchymal
involvement. Prognostic information in both scenarios is
based on data regarding the estimation of outcome from
scientific publications [25, 26]. Video A and B differ solely
in prognostic framing. Video A exemplifies a more optimis-
tic framing, whereas Video B illustrates a more pessimistic
framing. The differing degree of optimism is achieved by
varying selected text passages. The number of empathic
statements is equal and both vignettes conclude with an
identical reassurance of non-abandonment by the phys-
ician. Other aspects of the physician-parent communica-
tion, e.g., the setting/environment, the consulting physician,
the parents, and the content of the consultation, are stan-
dardized. The length of both videos is about 3min each. A
female physician was chosen to communicate the progno-
sis. This reflects the clinical reality of the NICU at the
UMC Mainz. The parents are a heterosexual Caucasian
couple around 25–30 years old. We have chosen this con-
stellation because their proportion among our local NICU
parents and their willingness to participate in research pro-
jects is relatively high, without the intention to discriminate
against people of other ethnicities or sexual orientation
which are also represented on our NICU. The underlying
assumption is that the proportion of heterosexual Cauca-
sian parents and couples among the participants would be
the largest, and by representing such a parent couple, their
identification with the videos and thus the response quality
could be optimized.
Prior to exposure to the intervention, participants are
provided with a short (approximately 1.5 min)
explanatory film contextualizing the medical
consultation. A fictional premature infant named Luisa
is born with a gestational age of 23 weeks + 5 days due
to an amniotic infection syndrome. Luisa experiences an
intraventricular hemorrhage on her third day of life. On
this occasion, the parents are contacted by telephone by
the attending neonatologist. They are asked to come to
the unit in person for the purpose of a physician-parent
conversation in a timely manner.
Explanation for the choice of comparators {6b}
Since the optimum framing of prognostic disclosure to
parents in the context of complications with an
associated unfavorable prognosis in the NICU setting is
unknown, we decided to depict two opposing levels of
optimism (more optimistic vs. more pessimistic) out of a
spectrum of gradations of optimism. As the introduction
indicates, these two selected opposing gradations are
found in clinical practice as well as in research.
Accordingly, this selection is suitable for the purpose of
the present project. Stimulus for the choice of
comparators as well as for the use of scripted video
vignettes as study material originated from a study in
adult oncology investigating the influence of more or
less optimistic communication on the perception of
physician compassion [22]. The selection of the
questionnaires chosen to assess physician
professionalism and physician compassion was inspired
by the aforementioned and one related study [22, 27].
The conception, cinematic realization and application
of the video vignettes comply with recommendations by
Hillen and van Vliet [28, 29]. Case vignette and scripts
were designed with an interdisciplinary team and
implemented with professional actors and filmmakers.
Criteria for discontinuing or modifying allocated
interventions {11b}
Individual preterm end of study
The individual participant can discontinue the study at
any time. The study-related and intervention-related
risks for participants are assumed to be minimal. Due to
the fact that the study will be conducted as an online
survey, among other things, there is no risk of commut-
ing accidents. In addition, the interventions are videos
which represent a fictional scenario and do not involve
any intervention in the current clinical reality, and the
actors as well as the setting (i.e., the filming location) are
unknown to the parents. Deliberate care was taken to
minimize the relatability to the parents’ own story.
Preterm end of entire study
Please see the “Interim analyses {21b}” section.
Strategies to improve adherence to interventions {11c}
Data collection is performed on 1 day within
approximately 30-35 min (time for procession of the on-
line survey) and thus participant adherence can be ex-
pected. However, detailed education and transparency
regarding the study procedure prior to the online survey
are intended to prepare participants as best as possible
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for study participation and to minimize the risk of non-
adherence or drop-out. Education includes the duration
of the online survey (baseline questionnaire, single vid-
eos, post-intervention questionnaire) and the request to
complete the study to the last page in case of participa-
tion. The communication of availability for questions or
in case of concerns at any time serves the same purpose.
Relevant concomitant care permitted or prohibited
during the trial {11d}
Not applicable, as there is no interference with
concomitant care. The video vignettes depict a fictitious
scenario and participants’ infants have already been
discharged from the NICU.
Harms {22}, and provisions for ancillary and post-trial care
{30}
Watching the videos and the subsequent answering of
questions may cause an emotional reaction in parents.
However, the risk of experiencing significant distress is
considered to be minor. Parents who feel too distressed
can discontinue the questionnaire at any time (see the
“Individual preterm end of study” paragraph in the
“Criteria for discontinuing or modifying allocated
interventions {11b}” section). In addition, participants in
distress are encouraged to contact the research team to
jointly discuss whether their case requires consultative




1. Parents’ preference with regard to prognostic
framing, i.e., the parents’ preference for video A or
B after watching both videos.
Secondary outcomes and associated hypotheses
1. Parents’ state-anxiety due to/after watching each
video: Parental state-anxiety is greater with a more
pessimistic prognostic framing than with a more
optimistic framing.
2. Parents’ satisfaction with prognostic framing in the
first video: Parental satisfaction is greater with a
more pessimistic prognostic framing than with a
more optimistic framing.
3. Realism of the evaluation of the conveyed prognosis
following the first video: With a more pessimistic
prognostic framing, the parents’ appraisal of
prognostic severity is more realistic than with a
more optimistic prognostic framing.
a. Subjective evaluation of the severity of the
prognosis: When prognostic framing is more
pessimistic, parents indicate a higher degree of
severity with regard to the infant’s prognosis
(subjective evaluation) when compared to more
optimistic framing.
b. Objective ability to recall conveyed prognostic
information: When prognostic framing is more
pessimistic, parents show less deviation in the
recall of conveyed probabilistic data (objective
evaluation) with regard to the child’s prognosis
when compared to a more optimistic framing.
4. Degree of optimism with regard to the infant’s
future (future optimism) following the first video:
When prognostic framing is more pessimistic,
parents show less optimistic expectations
concerning the infant’s future prospects, i.e., its
overall survival on the one hand and its survival
free from impairment(s) on the other hand, when
compared to more optimistic framing.
5. Degree of hope with regard to the infant’s future
(future hope) following the first video: When
prognostic framing is more pessimistic, parents
express less hope with regard to the infant’s future
when compared to more optimistic framing.
6. Degree of preparedness by the medical consultation
(first video) to make a shared therapeutic decision:
When prognostic framing is more pessimistic,
parents indicate a higher level of being adequately
informed about the prognosis and of feeling
prepared for shared therapeutic decision-making
when compared to more optimistic framing.
7. General impression of the consulting physician
(first video) on parents: A neonatologist conveying
a pessimistically framed prognosis makes a better
general impression on participants than one
conveying it optimistically framed.
8. Professionalism of the consulting physician (first
video): Parents assess a neonatologist conveying a
pessimistically framed prognosis as more professional
than one conveying it optimistically framed.
9. Compassion of the consulting physician (first video):
Parents assess a neonatologist conveying a
pessimistically framed prognosis as less compassionate
than one conveying it optimistically framed.
Further outcomes and associated presumptions:
10. Perception of prognostic framing following each
video: Parents rate both videos differently in terms
of the level of optimism in prognostic framing,
whereby prognostic framing in video A is perceived
as more optimistic when compared to video B.
11. Parents’ personal preference of gradation of
prognostic framing (level of optimism) after
watching both videos: Parents’ personal preference
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of the level of optimism in prognostic framing after
watching both videos corresponds to a more
nuanced gradation of the direction of prognostic
framing indicated via their preference for video A
or B.
12. Importance of physician-parent communication in
general and of prognostic information in particular
(on completion of the survey): Parents rate selected
aspects of physician-parent communication in gen-
eral and of prognostic disclosure in particular as ra-
ther important.
13. Burden due to study participation in general and to
interventions in particular (on completion of the
survey): Parents’ self-assessed burden by participa-
tion in the study in general and by watching the
videos in particular is low.
A tabular overview of all relevant outcome measures
and the time points of assessment thereof (data
acquisition) complemented by a detailed description of
all collected baseline data, of all outcome measures and
of the respective data collection instruments can be
found in the “Data collection: outcome measures and
assessments” section.
Participant timeline {13}
Study procedures, examination methods, and outcome
assessment
Figure 1 provides an overview of the study sequence and
corresponds to the participant timeline. Following the
recruitment of participants, the online survey based on a
two-part questionnaire with embedded scripted video vi-
gnettes (interventions) is applied.
Sample size rationale {14}
At first, we conservatively assumed that only one parent
of each child participates. The data can be arranged in a
2 × 2 table, with columns defining the sequence order
“AB” vs. “BA” and rows defining whether the first video
was preferred over the second one. Then, the square
root of the odds ratio is a period-adjusted estimate of
the preference ratio, i.e., a general tendency toward or
against preferring the latter video is corrected for. As-
suming that there is, in fact, no such period effect, the
discriminatory power for detecting a preference ratio of
3:2, based on a two-sided chi-square test with level a =
0.05, is 0.80, if 194 individual parent decisions are evalu-
able (using SAS software’s proc power). Assuming a sub-
stantial period effect, such that the first video is
preferred with odds 1:1 in sequence group “AB” and
with odds 9:4 in group “BA,” the period-adjusted prefer-
ence ratio results, but then the required case number is
204. Assuming further that 95% of participating parents
actually decide and share their preference, 215 families
are to be recruited. If we now assume that always both
parents participate and that the concordance of the
evaluation corresponds to a kappa of 0.5, then at least
153 families would have to be recruited (using the stand-
ard formula for cluster randomized trials and multiply-
ing 204 with the variance inflation factor 1.5 results in
306 parents, i.e., in 153 families). A blinded sample size
reassessment is planned after 50 to 70 parents. For de-
tails, please see the “Interim analyses {21b}” section.
Participant recruitment {15}
Potential participants, i.e., parents or guardians
(individuals or couples), whose preterm infants were
born extremely preterm, i.e., with a VLBW (< 1500 g),
between 2010 and 2019 and who received postnatal care
in our NICU (see “Inclusion criteria” paragraph in the
“Eligibility criteria {10}” section) are mainly identified via
the electronic database (contact list) of the designated
follow-up consultation program intended for former
VLWB patients of our NICU, to which the latter are af-
filiated for the first 2 years after discharge. In addition,
the identification of potential participants is complemen-
ted by research in the electronic hospital database of the
UMC Mainz. Excluding bereaved parents, all parents
and guardians are to be invited to participate in our
study. Contact with potential participants is established
via personal and electronic means. Participants receive a
letter with information material (written information)
two weeks ahead of a phone call by a research team
member (oral information). The material comprises a
synopsis of the research project, information concerning
data protection regulations, the declaration of consent,
and contact details of the research team. The telephone
contact is intended to provide a more detailed, in-depth
explanation of study-related content and space for quer-
ies. The concomitant identification of parents not eli-
gible for participation is a further purpose of the
conversation. In addition, potential participants will be
contacted personally at neurodevelopmental follow-up
appointments, and through a local parents’ mutual sup-
port group.
Persons interested in participation contact the
research team electronically (e-mail). Parents and
guardians are asked to simultaneously include in the
electronic feedback to the research team whether one or
both parents of the same child will participate. In
response, the participants are provided with their
personal access data (link and password) for the
password-protected online survey. The personal link
containing the information which study group the re-
spective participant is assigned to is part of the first e-
mail. For data security reasons, the password (a multi-
digit access code) is communicated in the second e-mail.
Although the recruitment procedure implies contacting
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and educating parents of the same preterm infant to-
gether, during participation they are not treated as an
entity. Individual parents are considered equally as re-
lated parents of the same child. A special provision in
the case of participation of both parents is that they are
assigned to the same study group. This is to ensure that
the assumed common response tendency (covariance)
based on a couple’s shared experience of prematurity is
taken into consideration. However, in order to be able to
simultaneously investigate sex-specific or parent-specific
differences in processing the same lived experience, re-
lated parents are marked as such in the data set. This is
ensured by the multi-digit access code containing a
matching prefix for parents of the same child.
Assignment of interventions: allocation and
blinding
Sequence generation {16a}, allocation concealment
mechanism {16b}, and implementation {16c}
Concealed randomization of participants will be
performed in blocks of variable length. Randomization
lists will be stratified by the participating parents (single/
both) of the same preterm infant, i.e., into the three strata
“participation of mother only,” “participation of father
only,” and “participation of both parents.” The
randomization lists will be generated by JK who is not
involved in clinical patient care and data acquisition. With
regard to the parent-participants, one list for each stratum
will be compiled. Subsequently, sequentially numbered,
sealed, and opaque envelopes indicating the respective
study group will be prepared by an employee of the UMC
Mainz not involved in clinical patient care and data acqui-
sition. Participants will be enrolled by FF. Allocation will
be performed by an employee of the UMC Mainz not in-
volved in participant recruitment outside the online sur-
vey software and in the order of consent after recruitment
of the participants. In case both parents of the same child
participate, they receive the same allocation.
Who will be blinded {17a}, procedure for unblinding if
needed {17b}
Actors (video vignettes) were and participants will be
blinded to the hypotheses of the study. Research team
members (including outcome assessors and data analysts)
as well as trial participants cannot be blinded for the
intervention sequence. The videos though will not be
labelled explicitly as pessimistic or optimistic for the
parents and the sequence of interventions will be neutrally
labelled. No procedure for unblinding is necessary.
Data collection: outcome measures and
assessments
Table 1 provides an overview of the data acquisition
including all important data (enrolment, baseline,
outcomes) as well as the respective time points of the
assessment thereof. The respective assessments (i.a., all
customized questions and validated instruments) are
described in detail in the “Data collection: outcome
measures and assessments” section under the heading
“Assessments: description of instruments used for
collection of baseline and outcome data”.
Plans for assessment and collection of baseline and
outcome data {18a}
Baseline and outcome data will be collected within the
framework of the two-part online survey. Entitlement to
take part in the online survey (second phase) ensues with
the signature of the electronic declaration of consent.
Randomization, i.e., balanced random allocation of partici-
pants to the two study groups, marks the conclusion of en-
rolment. Using the individual access data, participants can
process the password-protected two-part online survey on
the platform SoSci Survey (Dominik Leiner, 2019; URL:
https://www.soscisurvey.de). Both parts of the survey are
processed directly one after the other, i.e., without any tem-
poral separation. It will take the individual participant an
average of 30 to 35min to complete the two-part online
questionnaire. The distinction in two parts is exclusively
content-related. The first part of the online survey is identi-
cal for both groups. It consists of the assessment of baseline
data (baseline questionnaire) followed by the presentation
of the identical explanatory film. Subsequently, the two dif-
ferent video vignettes are presented in randomly assigned
sequence (cf. Fig. 1, AB vs. BA). The videos are embedded
in the post-intervention questionnaire. The latter comprises
the identical data acquisition for both groups after the first
video (data acquisition t1), after the second video (data ac-
quisition t2), and in conclusion (data acquisition tend).
Baseline questionnaire (data acquisition t0)
Recognizing the interindividual differences that exist
between parents may be an important resource in
gaining a better understanding of participants’
perceptions and preferences. For this purpose, a
selection of relevant participants’ characteristics is
assessed as potential factors influencing the parents’
preference for a more optimistic or a more pessimistic
prognostic framing as well as the secondary outcomes
within the framework of the baseline questionnaire. On
the assumption that prematurity can represent a special,
even transformative life event for parents [3], the data
collection at baseline additionally comprises questions
about the parents’ own experience of premature birth as
a special life event (adapted from FaBel questionnaire).
The additional selection of personality traits assessed,
consists of resilience (BRS), (in)tolerance of uncertainty
(UGTS), dispositional optimism/pessimism (SOP2),
dispositional hope (HHI-D), depressivity and general
Forth et al. Trials          (2021) 22:884 Page 9 of 21
anxiety (PHQ-4) as well as situational anxiety (STAI-
SKD) and anxiety as a personality trait (trait-scale of the
STAI). The assessed baseline data serve as the basis for
potential subgroup analyses (for details see the
“Methods for additional analyses {20b}” section).
Post-intervention questionnaire (data acquisition t1, t2, tend)
The post-intervention questionnaire serves the purpose
of assessing primary as well as secondary outcome mea-
sures. All secondary outcomes are assessed solely after
the first video (data acquisition t1). The primary out-
come and the majority of the further outcomes are
assessed solely after the second video (data acquisition
t2). One secondary and one further outcome are assessed
after each video (data acquisition t1 and t2).
Primary outcome
1. Parents’ preferences with regard to prognostic
framing, i.e., parental preference for video A or B
after watching both videos is assessed using the
preference for one of the videos A or B as surrogate
for different prognostic framing. A dichotomous
question (1 = first video; 2 = second video) is used for
this purpose. Qualitative complement to the primary
outcome (quantitative): In case parents want to
substantiate their choice, e.g., if they do not explicitly
prefer one of the videos or have a strong preference,
a free text field is provided for this purpose.
Secondary outcomes
1. Parental state-anxiety is assessed using the German
short version (5 items) of the state scale of the
Table 1 Overview of time points of exposure to interventions and data acquisition
Enrolment Baseline questionnaire Post-intervention questionnaire
Time point t−1 t0 t1 t2 tend
Enrolment
Eligibility feedback to RT ●





Prematurity as special life event ●
Relevant psychological characteristics ●
Interventionsa Video A/B Video B/A
Primary outcome
1 Preference video A or B ●
Secondary outcomes
1 State-anxiety ● ●
2 Satisfaction (framing) ●
3 Realism of prognosis evaluation ●
a Severity of prognosis ●
b Recall of prognostic information ●
4 Future optimism ●
5 Future hope ●
6 Preparedness for decision-making ●
7 Physician general impression ●
8 Physician professionalism ●
9 Physician compassion ●
Further outcomes
10 Perception of framing ● ●
11 Preference gradation of framing ●
12 Importance of communication ●
13 Burden by study ●
Notes. RT: Research team. aThe interventions video A and B are embedded in the post-intervention questionnaire. Prior to exposure to the first video (A or B,
depending on study group) participants watch a short explanatory film
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State-Trait Anxiety Inventory (STAI-SKD) after
each video. The change in state-anxiety due to/after
watching the first video is determined as the differ-
ence in state-anxiety at time points t0 and t1. The
change in state-anxiety due to/after watching the
second video is assessed analogously. Qualitative
complement to the secondary outcome 1 (quantita-
tive): A free text field following the STAI-SKD after
each video gives participants the opportunity to de-
scribe how they feel after watching the videos in
their own choice of words.
2. Parents’ satisfaction with prognostic framing in the
first video (customized question) is assessed using a
unimodal, fully verbalized 7-point rating scale (1 =
not at all satisfied; 7 = very satisfied).
3. Following the first video, the realism of the
evaluation of the conveyed prognosis is assessed by
the degree of concordance between subjective
evaluation and objective ability to reproduce the
prognostic information provided: (a) Subjective
evaluation of the severity of the prognosis
transmitted is assessed using a parent-rated custom-
ized statement via a fully verbalized 7-point rating
scale (1 = very severe; 7 = not at all severe). (b) The
objective ability to reproduce the transmitted infor-
mation is based on the recall of outcome data in
numerical values (relative probabilities in %). As-
sessment consists in the selection of percentages
ranging from 0 to 100 percent in increments of ten
(survival) or twenty-five (impairment).
4. The degree of optimism with regard to the infant’s
future following the first video is determined by the
rating of two customized statements (a) on survival of
the complication per se and (b) on survival without
impairment via the respective unimodal, fully
verbalized 7-point rating scale (1 = not optimistic at
all; 7 = very optimistic). It is considered in the analysis
that the degree of optimism may depend on the par-
ticipants’ basic attitude toward life initially assessed
using the Scale Optimism-Pessimism-2 (SOP-2).
5. The degree of perceived hope following the first
video is assessed rating a customized question on a
unimodal, fully verbalized 7-point rating scale (1 =
not at all hopeful; 7 = very hopeful). A possible cor-
relation between the individual degree of hope
assessed at baseline using the German version of
the Herth Hope Index (HHI-D) and the degree of
hope following the video is examined.
6. Participants evaluate how well they feel prepared by
the medical consultation (first video) to make a
shared decision regarding the infant’s treatment
(customized question). A fully verbalized 7-point
rating scale (1 = not at all prepared; 7 = fully pre-
pared) is used for assessment.
7. Following the first video, the consulting physician’s
general impression (customized question: “What is
your general impression of the doctor?”) on
participants is assessed using a fully verbalized
5-point rating scale (1 = poor; 5 = very good, sum
score: range 9–45). The general impression
corresponds to a global assessment of the physician
on the basis of a widely used evaluation standard
(“school grades”) and is supplemented by a more
differentiated assessment of individual aspects, i.e.,
physician characteristics, in two follow-up
questions.
8. Following the first video, the consulting physician’s
professionalism is assessed by means of the German
translation of 7 items of the General Medical
Council (GMC) Patient Questionnaire adapted from
the original by Campbell et al. [30].
9. Following the first video, the consulting physician’s
compassion is evaluated by means of the German
translation of the Physician Compassion
Questionnaire adapted from the original by Fogarty
et al. [31].
Further outcomes
10. To capture the perceived differences between both
video vignettes in the degree of optimism
(customized question), the latter is assessed after
each video using a 7-point rating scale (1 = not
optimistic at all; 7 = very optimistic). The assess-
ment is the basis for the analysis of intra- as well as
inter-group differences concerning the perception
of prognostic framing in the videos.
11. The participants’ hypothetic personal preference
with regard to framing of an unfavorable prognosis
in clinical reality (customized question) is assessed
after watching both videos using a unimodal, fully
verbalized 7-point rating scale (1 = not at all
optimistic; 7 = very optimistic).
12. Concluding the survey, parents are asked to
provide an assessment regarding the importance
of physician-parent conversations in general and
certain contents, i.e., the transmission of
prognostic data, in particular. For both topics, 4
customized items are rated using a fully verbalized
5-point rating scale (1 = strongly disagree; 5 = strongly
agree).
13. Concluding the survey, parents indicate whether
they feel burdened due to study participation in
general or due to watching the videos in particular
(customized question). The assessment is based on
the rating of 2 customized items on a 5-point rating
scale (1 = not at all burdened; 7 = very much
burdened).
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Assessments: description of instruments used for
collection of baseline and outcome data
Sociodemographic variables
Sociodemographic variables include age, sex, sociocultural
background, highest educational attainment (school,
professional), occupation and medical background
(general medical and NICU expertise). Additionally, the
data acquisition at baseline comprises questions regarding
the own family (i.a., family status, number of children) as
well as characteristics of the preterm infant (i.a., year of
birth, gestational age at birth, birth weight).
German version of the Impact on Family Scale (FaBel
questionnaire)
The German version of the American “Impact on Family
Scale” [32] namely the “Familien-Belastungs-Fragebogen”
(FaBel questionnaire) [33] is a self-assessment tool used to
assess the impact of a child’s chronic illness or disability
on different dimensions of family life. Since early preterm
birth can be regarded as a chronic condition on the one
hand, and typical complications associated with it often
result in impairments on the other, singular items of the
FaBel questionnaire were identified as suitable to be se-
lected as a base for the formulation of items on respective
topics. In the German version of the scale, parental (dis)-
agreement with each of the 33 items is assessed using a 4-
point Likert scale (1 = strongly agree to 4 = strongly dis-
agree). Each item is assigned to one of five dimensions
reflected in the respective number of subscales: everyday
and social burden (15 items), personal burden/worries
about the future (5 items), financial burden (4 items), bur-
den on siblings (6 items), and problems in coping/mastery
(3 items). The average rating of these items corresponds
to the score of each subscale. Higher scores in the sub-
scales indicate a higher burden in the respective dimen-
sions, a higher average score of all item scores indicates a
higher global familial burden. Testing and evaluation of
the German version was performed with a sample of 273
families of children with chronic conditions or disabilities
[33]. Factor analysis yielded a five-factor solution instead
of a 1-factor plus a 4-factor solution (English version)
[33]. The internal consistency for the overall score (α =
.89) can be rated as good [33]. For the five subscales, reli-
ability can be rated as questionable to good with the in-
ternal consistency ranging from α = .60 to α = .87 [33]. In
summary, psychometric testing of the FaBel questionnaire
revealed acceptable construct validity (slight deviation
from original scale), good internal consistency (Cronbach’s
α), very good to excellent scale fit (differential factorial val-
idity), and good discriminant validity [33].
Within the framework of the COPE-Trial, participants
will be asked to what extent premature birth has (had)
an impact on family life (1 item), family cohesion (1
item), and the family’s financial security (4 items). For
each item, parents will indicate on a 4-point Likert scale
to what extent they (dis)agree with the respective state-
ment. Five of the six items were inspired by five items of
the FaBel questionnaire. The item assessing the impact
of prematurity on family cohesion was inspired by the
item F12 of the subscale “problems with coping/mastery”
of the German version of the FaBel questionnaire. The
four items with respect to the impact of prematurity on
the family’s instrumental resources were adapted to the
items F1-F4 of the subscale “financial burden” of the
same scale. Concerning the selection of adapted items in
the analysis of results in the present study, each item will
be considered individually, with a higher score indicating
a higher load regarding the different dimensions covered
by the abovementioned items. In addition, an average
score can be calculated for the 4 items concerning finan-
cial stress. A higher score in this regard also indicates a
higher financial burden.
German version of the Brief Resilience Scale (BRS)
The Brief Resilience Scale (BRS) is a self-report instru-
ment used to assess an individual’s ability to recuperate
from stress despite difficult circumstances [34]. The
German version translated, revised, and evaluated by
Chmitorz et al. is used in the present study [35, 36]. The
short instrument comprises 6 items rated on a 5-point
Likert scale (1 = strongly disagree; 5 = strongly agree).
The items 1, 3, and 5 are positively phrased whereas the
items 2, 4, and 6 are negatively formulated. The latter
have to be reversely coded to calculate the mean of all
items (range 1–5). Higher average scores (mean) indicate
a higher ability to recuperate from stress. Psychometric
properties of the German version of the BRS were
assessed by use of data from a population-based sample
(sample 1) of 1.481 healthy adults aged 18 to 75 from
Mainz (Germany) and a representative sample (sample
2) of 1.128 persons from the German general adult
population [35, 36]. Differing from previous research
(one- and two-factor model), factorial analyses yielded
evidence for a method-factor model (both samples). The
use of the unidimensional BRS score is however recom-
mended by the authors. Reliability (Cronbach’s α) and
composite reliability (McDonald’s omega) were rated
good in both samples (α = .85 and ω = .85). Sufficient to
fair convergent validity and acceptable to good discrim-
inant validity as well as construct validity were demon-
strated [35, 36]. Normative data is available for a
German general population sample [36].
German Uncertainty Tolerance Scale
(Ungewissheitstoleranzskala, UGTS)
The Ungewissheitstoleranzskala (UGTS), i.e., the
German Uncertainty Tolerance Scale, enables the
differentiation of persons tolerant and persons intolerant
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to uncertainty [37]. The unidimensional self-rating scale
consists of 8 items phrased in the first person used to as-
sess the respondent’s evaluation of and/or coping with
uncertain situations (e.g., “I like unexpected surprise”).
Each item is rated on a 6-point rating scale (6 = strongly
agree; 1 = strongly disagree). Five items describe uncer-
tainty tolerance whereas 3 items (items 2, 5, and 8) de-
scribe uncertainty intolerance. The latter have to be
recoded in order to calculate the mean (range 1–6).
Higher scores indicate higher uncertainty tolerance,
whereas lower scores indicate higher uncertainty intoler-
ance. The internal consistency ranges from Cronbach’s α
= .66 to .72 and can be rated as acceptable to good [37].
The UGTS was based on a one-factor model which
could be confirmed in multiple studies, and data con-
cerning construct validity and differential validity are
available [37]. For the UGTS, no normative data, but
mean values and standard deviations for certain samples
are available [37].
German Scale Optimism-Pessimism-2 (SOP2)
The SOP2 is a short self-rating instrument consisting of
two items [38, 39]. The two-dimensional scale is used to
assess the construct optimism-pessimism, i.e., a respon-
dents’ dispositional optimism and/or pessimism. On a 7-
point Likert scale, respondents indicate how optimistic
(1 = not at all optimistic; 7 = very optimistic) or pessim-
istic (1 = not at all pessimistic; 7 = very pessimistic) they
are in general. Precondition to calculate the average
score SOP2 (mean) is the recoding of the item pessim-
ism (range 1–7). Lower SOP2 scores indicate higher pes-
simism and higher scores signify higher optimism. There
is no consensus in the literature concerning the dimen-
sionality (one- vs. two-dimensional) of the
conceptualization of the construct optimism-pessimism.
Consistent with data from sample 1, the SOP2 was based
on a general factor model [38, 39]. The SOP2 was devel-
oped and validated within three studies (series) using
three samples - one quota sample with two waves (sam-
ple 1; Nfirst wave = 539, Nsecond wave = 338), one quota
sample from the internet (sample 2; N = 741), and one
large sample representative for the German adult popu-
lation (sample 3; N = 1134)—by Kemper et al. [38, 39]
The composite reliability (McDonald’s ω) of the SOP2
was rated sufficient to good (ω = .74–.83) [38, 39]. Data
concerning convergent and divergent validity (e.g.,
strong correlation with LOT-R and life satisfaction), and
expected correlations confirming the construct validity
are available [38, 39]. In large-scale studies, psychomet-
ric evidence for the German version of the SOP2 was
shown [40]. Normative data exist for different groups
separated by age, gender, and education for a
population-representative sample (resident population in
Germany > 18 years) [38, 39].
German version of the Herth Hope Index (HHI-D)
The Herth Hope Index is a 12-item self-report instru-
ment to assess the construct of hope [41]. Various di-
mensions of hope as well as the coexistence of
generalized as well as particularized hopes are reflected
in the 12 statements (items). The items are rated on a 4-
point Likert scale (1 = strongly disagree, 4 = strongly
agree). The individual level of hope is assessed by calcu-
lating the total score (range 12–48). In doing so, the
negatively phrased items 3 and 6 have to be recoded.
Higher scores indicate a higher level of hope, lower
scores a lower level of hope. The original version of the
HHI was translated by Geiser et al. and validated with a
sample of cancer patients in treatment at the University
Hospital of Bonn, Germany (n = 192) [42]. The original
3-factor structure of the HHI could not be replicated in
the sample and a 1-factor structure was proposed [42].
That being the case, it is recommended that only the
total score be used to indicate an individual’s level of
hope. The internal consistency for the overall score
based on the German sample is α = .82 and can be rated
as good [42]. Test-retest reliability can equally be rated
as good (α = .80) [42]. Data concerning solid convergent
validity (e.g., significant correlation of the HHI-D sum
score with LOT subscale optimism and the subscale of
pessimism) and expected correlations confirming the
construct validity are available [42].
German version of the 4-item Patient Health Questionnaire-
4 (PHQ-4)
The PHQ-4 is a 4-item self-report questionnaire consist-
ing of two subscales, namely the 2-item depression scale
PHQ-2 and the 2-item anxiety scale GAD-2 [43]. The
ultra-brief instrument is used to assess depressivity (de-
pressive disorders) and anxiety. By rating the 4 items of
the questionnaire (e.g., “feeling down, depresses or hope-
less”) on a 4-point rating scale (0 = not at all, 1 = several
days, 2 = more than half the days, 4 = nearly every day),
respondents indicate the frequency of their occurrence
within the past 2 weeks. The German version of the
PHQ-4 has been validated and standardized in the gen-
eral population by Löwe et al. [44] with a sample of
5030 participants. Confirmatory factor analyses showed
a very good fit for a two-factor model. The internal
consistency of the subscale PHQ-2 (α = .78) and GAD-2
(α = .75) as well as of the average score (α = .82) can be
rated as acceptable considering the shortness of the sub-
scales as well as of the questionnaire. Study findings sug-
gest good construct validity (correlation with selection
of self-report scales and with demographic risk factors
for anxiety and depression) in the general population.
On the basis of available studies, convergent, divergent,
and factorial validity of the PHQ-4 can be rated as good
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[43, 44]. Normative data is available for a German gen-
eral population reference group [44].
German version of the trait scale (STAI-T) of the State-Trait
Anxiety Inventory (STAI)
The State-Trait Anxiety Inventory is a self-rating instru-
ment consisting of two separate questionnaires with 20
items each [45]. One of the questionnaires, namely the
state-scale of the STAI, serves the purpose of determining
anxiety as a state, i.e., the respondent’s current, situational
anxiety. The second questionnaire, the trait-scale, is used
to assess anxiety as a trait, i.e., the respondent’s disposi-
tional anxiety (independent of a particular situation). In
both questionnaires, the rating of 20 brief self-statements
on a 4-point rating scale is required. In the case of the
present study, only the trait-scale is applied. To assess
situational anxiety, a shorter version of the original state-
scale is used (see next section). Verbal anchoring differs in
both questionnaires and describes frequency dimensions
in the case of the traitscale (1 = almost never, 2 = some-
times, 3 = often, 4 = almost always). Thirteen of the items
describe characteristics positively formulated, i.e., describ-
ing presence of anxiety. The remaining 7 are negatively
phrased, i.e., indicating absence of anxiety. The latter have
to be recoded before calculating the sum of all 20 scores
on the individual items. The total score (range 20–80) cor-
responds to a global assessment of the respondent’s dispo-
sitional anxiety. Higher scores indicate a higher trait-
anxiety. The original version of the STAI-T was translated
to German by Laux et al. and validated with data from
multiple subsamples (healthy persons as well as collectives
of people with a mental health condition) [46]. Internal
consistency of the average STAI-T score is α = .90 and
can be rated as good to excellent [46]. The construct val-
idity of the STAI is confirmed by high correlations with
scales related to the construct [46]. Normative data are
available for different groups (students, different clinical
groups) separated by age and gender [46].
German (5-item) short version of the state scale of the
State-Trait Anxiety Inventory (STAI-SKD)
The short version of the state-scale of the STAI is used
to assess the respondent’s situational anxiety [47]. The
STAI-SKD consists of 5 items concerning the respon-
dent’s current state of tension, excitement, nervousness,
fear, and worry rated on a 4-point rating scale (1 = not
at all; 4 = very much so). Compared to the original
state-scale comprising 20 items, all 5 items of the short
version are worded toward the presence of anxiety. The
extraction of the short version from the original STAI
state-scale was based on a first sample of university stu-
dents (N = 65). Confirmatory factor analysis yielded a
two-factor structure in a second sample of university
students (N = 191). In a third sample of university
students (N = 80), the construct validity of the STAI-
SKD (additional to discriminant validity assessed in sec-
ond sample) and its sensitivity to change were assessed
[47]. The expected two-factor structure of the STAI-
SKD with the two factors emotionality and worry was
confirmed [47]. However, due to the high correlation of
both factors, the use of the total score is recommended
to indicate a respondent’s state-anxiety. The internal
consistency for the overall score based on three German
samples of university students ranges from α = .76 to α
= .85 and can be rated acceptable to good [47]. The in-
strument’s sensitivity to change was confirmed [47].
That is determinant for its use in the framework of the
present study. Expected correlations with other parame-
ters confirming construct validity are available [47].
Physician Professionalism—GMC Patient Questionnaire
The Physician Professionalism Questionnaire corresponds
to a selection of a 7-item questionnaire adapted from the
General Medical Council (GMC) Patient Questionnaire
[30]. The original patient questionnaire consists of 18
items, 11 of which are used to measure a patient’s percep-
tion of the physician’s performance. To evaluate the phys-
ician professionalism within the framework of the present
study, from these 11 items the 7 respective items (3a–g)
were selected. The selection of items was adapted from
Tanco et al. [22, 27]. Professionalism will be assessed via
the respondent’s evaluation of the attending physician’s
politeness, of the pleasantness of the atmosphere in his/
her presence, of the physician’s ability to listen to the pa-
tient, to assess the patient’s condition, to explain the con-
dition and its treatment to the patient, and to involve the
patient in the treatment decision. Analog to the original
questionnaire, the evaluation will be realized by the use of a
verbally and numerically anchored 5-point rating scale with
the scale points poor (= 1), less than satisfactory (=2), satis-
factory (=3), good (=4), very good (= 5). In the context of
the present study, higher scores on individual items will be
interpreted as greater competence in the trait in question.
In addition, a total score (range 7–35) of all items can be
calculated with a higher sum score corresponding to higher
global professionalism. Analog to the reference studies [22,
27], the cut-off for professionalism will be set at ≥ 4. The
internal consistency of the original 9-item questionnaire
can be rated as excellent (α = .962) [30]. Translation by a
native speaker as well as retranslation have occurred. The
phrasing of the items was adapted to the context of the
study (e.g., use of parents instead of patients).
Physician Compassion Questionnaire
The applied version of the Physician Compassion
Questionnaire comprises 5 items used to assess
physician compassion. The 5 items correspond to five
dimensions of compassion evaluated on a 10-point
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numerical rating scale each (polarity profiles with 10
scale points each). The five dimensions reflected in the
questionnaire are as follows: warm-cold, pleasant-
unpleasant, compassionate-distant, sensitive-insensitive,
caring-uncaring. To determine the global compassion of
the consulting physician, the cumulative value (sum
score) of the 5 scales is calculated (range 5–50). Higher
scores indicate higher physician compassion. For the
purpose of the present study, the version of the ques-
tionnaire used by Tanco et al. [22, 27] was translated to
German and retranslated by a native speaker. Concern-
ing the original instrument developed by Fogarty et al.
[31], internal consistency can be rated as excellent (α =
.92).
Plans to promote participant retention and complete
follow-up {18b}
The provision of thorough information (transparency)
about the study, the availability of the research team for
queries at any time, and the possibility of flexible
processing of the online survey in terms of time and
space are intended to promote participant retention and
completion of the questionnaire.
Data management and quality assurance {19}
Data management and quality assurance will follow the
FAIR principles [48]. The management of data from project
planning to storage and accessibility (flow of the study
data) will be documented and updated by the principal
investigator (FF) on an ongoing basis. FF will further be
responsible for the assessment and documentation of
missing data. In the case of missing data, parents will be re-
contacted and missing values will be obtained.
The following data with regard to the course of the
study will additionally be assessed: Number of parents
eligible and approached, number of parents excluded
(including reasons for exclusion: participation refused/
rejected, exclusion criteria met, other reasons), number of
parents included and number of parents randomized to
each study group/respective scenario, number of parents
discontinuing the trial, number of parents included in
final analysis (including reasons for non-analysis).
Statistical methods
Statistical methods for primary and secondary outcomes
{20a}
SPSS in the latest version (IBM, Armonk, NY, USA) and
the R software (R Core Team, Vienna, Austria; URL
https://www.R-project.org/) will be used to conduct all
statistical analyses.
Descriptives
For all variables (baseline characteristics, primary,
secondary, and further outcomes), standard descriptive
statistics including means, medians, standard deviations,
ranges, and proportions will be determined. Baseline
characteristics will be reported for both study groups. In
addition, for the primary, the secondary as well as for
the further outcomes, appropriate effect estimates will
be reported with 95% confidence intervals.
Inferential statistics
The primary outcome is the answer to the binary
question whether a participant prefers the first or
second of the two videos (presented in different
sequence in both study groups). We will present results
as 2 by 2 table of preference (first or second video) vs
the sequence of presentation (AB and BA). Then the
square root of the odds ratio will be used as an effect
measure which is adjusted for systematic presentation
order effect (either for the first or for the latter video).
In order to also adjust for dependent response within
families this odds ratio and a 95% confidence interval
will be calculated by fitting a marginal logistic model for
dependent response. For this purpose, parents are
considered as cluster of size 1 or 2. The exponentiated
halved coefficient of the factor “sequence” (A then B
coded as 0, B then A coded as 1) is used as the period-
corrected estimate of the odds for preference for inter-
vention A. The test of the null hypothesis is performed
as Wald chi-square test at the two-sided 0.05 level.
Secondary outcomes will be analyzed by fitting
appropriate linear mixed models. In particular, for
outcome scales assessing each parent’s attitude at one
instance only, one random intercept term at a family level
will be entered. For the further outcome that is observed
after each video, the change between both observations t2
vs. t1 is modelled and the half-difference between se-
quence groups is taken as period-adjusted effect measure
and is reported with 95% confidence intervals.
Effect size
The effect size is the odds for preference for
intervention A. For sample size rationale, we considered
an effect size of 3:2 as a plausible relevant effect size.
For calculation of standardized effect sizes for
quantitative secondary outcomes, the outcomes are
rescaled such that the random intercept variance at a
parent level and the residual variance add up to one, and
will be referred to as Cohen’s d.
Interim analyses {21b}
No interim analysis for treatment effect is planned.
Because the period effect (i.e., the overall proportion
preferring the first video), the proportion of families
participating with both parents, the concordance between
parents, and the proportion of evaluable answers are
unknown, a blinded (using data on preference of video 1,
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parents’ ID, sex, and neutrally labelled sequence group)
sample size reassessment is planned after recruitment of
50 to 70 patients.
Methods for additional analyses (e.g., subgroup analyses)
{20b}
Details will be fixed in a statistical analysis plan after a
blind data review. Potentially prognostic factors for the
preferential attitude of parents will be analyzed by
entering them as additional explanatory variables into the
marginal logistic regression model described for primary
analysis. Similarly, the mixed linear regression models
envisaged for secondary outcomes will be extended by
entering potential predictors. Selected variables will be
investigated each at a time (univariable analysis) and in a
multivariable model. Further variables will be analyzed
exploratorily in univariable and multivariable models in a
forward step-up procedure.
Methods in analysis to handle protocol non-adherence
and any statistical methods to handle missing data {20c}
Concerning the primary endpoint, participants are asked to
decide their preference for one of the two videos after
having viewed both. Participants have the possibility to
complement their choice by adding an explanation in case
of indecision or for clarification in a free text field following
the assessment of the video preference, but no option to
respond “no preference.” We expect only few participants
to refuse answering by discontinuing the online
questionnaire. All observations with missing primary
outcome will be discarded independent of the reason,
because they contribute practically no information. Possible
consequences toward loss of power will be addressed
through the blinded sample size reassessment.
For secondary outcomes, missing values on item level
will be handled according to the guidance given by the
authors of the respective scale. Missing values on a scale
level either on outcomes or in explanatory variables will
be handled by complete case analysis, if this leads to less
than 5% case exclusion or by multiple imputation using
R package mice [49].
Plans to give access to the full protocol, participant-level
data, and statistical code {31c}
Please see the “Ethics and dissemination” section.
Oversight and monitoring
Composition of the coordinating center and trial steering
committee {5d}, data monitoring committee (DMC) {21a},
and plans for auditing trial conduct {23}
Quality assurance is ensured by the interdisciplinary
research team. The COPE-Trial and its respective inter-
ventions (video vignettes) are non-medical and expected
to be of minimal risk for participants. Consequently, no
safety concerns, overwhelming benefit, or futility are ex-
pected and a DMC will not be implemented. Therefore,
no external auditing is planned.
Discussion
Implications
The COPE-Trial addresses the question which framing
of prognostic disclosure is preferred by parents of pre-
term infants in the context of a severe complication.
More detailed knowledge of parents’ preferences is of
relevance, as it may contribute to improving the quality
of care in neonatology in the sense of parent-centered,
personalized communication in the long term. Of scien-
tific interest is whether and how communication can be
tailored to parents’ needs and preferences in the future.
Parents of preterm infants can provide valuable support
thanks to their own lived experience of preterm birth
and the associated challenges. We expect that a better
understanding of parents’ preferences concerning prog-
nostic disclosure will be of great value in tailoring con-
versations to parental needs. This may set the stage for
the best possible parental coping.
Limitations
A first possible limitation might be a selection bias due
to the (multi-step) recruitment approach, to the
eligibility criteria (esp. language skills) or to the intrinsic
motivation to participate (esp. gender differences).
Consequently, the heterogeneity of the study population
might not be reflected in the study collective which can
in turn limit the generalizability of the findings. In
addition, even though the recruitment procedure chosen
for this study allows for a heterogeneous sample, i.e., the
mapping of different perspectives, by including families
with children with very different outcomes, e.g., with or
without physical or cognitive impairments of different
degrees, at the same time, certain perspectives are
underrepresented. For example, despite the knowledge
of the value of the perspective of bereaved parents, it
was decided to approach the latter in a separate future
study.
Additionally, the personal data and psychological
characteristics of parents assessed as part of the baseline
(baseline questionnaire) can only be considered a
selective sample of potential factors that influence
parents’ preference and perception, and can
consequently be considered predictors thereof. Further
potentially influencing factors, such as the parental
worldview and the impact of the own infant’s biography
or the own NICU experience, respectively, cannot be
comprehensively illuminated in the framework of this
trial due to the scope and design of the present study
(quantitative vs. qualitative).
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The video vignettes do not reflect the full range of
prognostic framing, that is the entire spectrum/all
gradations of levels of optimism or possible manners of
disclosure of unfavorable prognoses in clinical practice,
but only two opposite extracts thereof. In addition, the
framing of communication in the two videos
intentionally differs mainly at the level of verbal
communication. However, it must be assumed that
participants might also perceive a difference at the level
of nonverbal communication (voice, facial expressions).
This is due to the natural convergence of content and
manner of communication (coherence) occurring when
a complex and uncertain message is communicated in
an empathetic way. In addition, the sex of the physician
is not randomized in the two videos. Depending on life
experience and family role models of the parents, the
gender of the physician could though potentially
influence the parental perception of and preference for
one video more than the prognostic framing itself.
Moreover, neither the physician nor the parents shown
in the videos have a migration background, i.e., they do
not reflect the diversity of ethnic backgrounds met in
(clinical) reality. This could lead to some participants
not being able to identify with the scenario or to not
consider the videos as reflection of their (clinical) reality.
As a consequence, this could also influence the results.
Finally, the generalizability of our findings is limited by
having confined to present only two video vignettes
overall as well as by the single-center setting. Note, how-
ever, that the choice of vignettes was specifically based
on findings from the literature and on the experience of
medical professionals (neonatologists) of the NICU at
the UMC Mainz. For the present project, we decided on
surveying solely parents and guardians of former pa-
tients of our center for the following reasons: On the
one hand, we assume that knowledge of the contextual
factors (e.g., communication practice of practicing physi-
cians, health care practice, parental collective) at our re-
search site will help us to better understand and
contextualize our research findings. On the other hand,
we regard our study as a starting point for exploring
feasibility of various design features before extending it
to other research sites.
Strengths
One of the strengths of the present project consists of
the use of validated psychological instruments and
consideration of test-theoretical findings in the develop-
ment of study-specific questions. The project is also
characterized by the high degree of standardization of
the videos. Furthermore, the comparability of both study
groups is guaranteed by use of the identical baseline
questionnaire, explanatory film, and post-intervention
questionnaire.
A further strength of the project is that it may pave
the way toward greater involvement of parents in
neonatal care research [50–52]. The COPE-Trial aims to
examine, on the one hand, the parents’ preferences con-
cerning the framing of disclosure of an unfavorable
prognosis (optimistic vs. pessimistic), and on the other
hand, to explore potential factors influencing the par-
ents’ preference as well as parents’ perception of, e.g.,
the prognosis itself. In order to ensure that the perspec-
tives of both communication partners of physician-
parent conversations in the context of the NICU are in-
vestigated in a comparable way and with the same the-
matic focus on prognostic framing (preferences and
effects), it is planned to conduct an exploratory trial
complementary to the present project to investigate the
neonatal doctors’ perspective analogous to and alongside
the ones of the NICU parents’ (note: The study protocol
of the complementary “COPE-Trial with neonatal doc-
tors” will also be made available upon its completion).
The almost analogous conduct of the study with parents
with the lived experience of prematurity as well as with
the clinical actors allows a direct comparison of both
perspectives. The study may therefore contribute to de-
termine the coherence of physician’s assessment of par-
ental needs and preferences and the reality of parental
need and preferences. Study findings may contribute to
increasing consideration of individual parental needs
and preferences with regard to physician-parent commu-
nication in neonatology and may help improve the qual-
ity of care in neonatology by strengthening a parent-
centered approach in this particularly challenging med-
ical field.
Ethics and dissemination
Research ethics approval {24} and protocol amendments
{25}
The study protocol including the data management as
well as one amendment to the study protocol were
approved by the Ethics Committee of the Medical
Association of Rhineland-Palatinate (Ethik-Kommission
der Landesaerztekammer Rheinland-Pfalz), Mainz,
Germany (reference number of the COPE-Trial: 2019-
14586). The COPE-Trial (original protocol and one sub-
stantial amendment) was registered at the German Clin-
ical Trials Register (www.drks.de/DRKS00024466) prior
to the commencement of participant recruitment. No
further amendments are planned. Any additions and
changes to the approved protocol would have to be sub-
mitted to the aforementioned Ethics Committee for re-
view. Amendments would require a specification of
reasons and can be considered part of the protocol upon
signature by an authorized person. Substantial changes
would require a new positive vote from the respective
Ethics Committee. Important changes to the protocol
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will be communicated to the responsible Ethics Com-
mittee via a designated online platform and will further
be added online to the German Clinical Trials Register
(www.drks.de/DRKS00024466). In case of important
modifications, we will also add the final version of the
study protocol as an appendix when publishing the
results.
Consent or assent {26a}, and confidentiality {27}
The trial is conducted in accordance with national and
international ethical and legal standards currently
applicable (e.g., the Declaration of Helsinki in its latest
German version). The legal basis for the protection of
personal data is the European General Data Protection
Regulation (GDPR). The processing of personal data is
performed only after effective declaration of consent
(Art. 6 para. 1 letter c) DSGVO).
All parents or legal guardians of infants born preterm
(eligible participants) will be informed personally.
Written and oral information regarding background and
objectives of the study, study procedure, and
participation (i.a., eligibility criteria) as well as data
protection regulations and (electronical) declaration of
consent will be provided to both parents or legal
guardians prior to participation. Participants are
encouraged to communicate additional questions to the
research team during the personal phone call or at any
other point in time. Participation is granted upon
consent. Electronic, informed consent to participate will
be obtained from all participants. In cases that consent
is not obtained, the participants are not proficient in
German, or the participant suffers from an acute
psychiatric illness, participation will be declined.
Participants may withdraw from the study at any time
without further explanation and without negative
consequences. Participants have the right to obtain
information on their personal data at any time
(including the provision of a copy free of charge) and to
request restriction, transfer, correction, or deletion of
their data. Furthermore, they may object to the
processing of their data at any time (Art. 13-21
DSGVO). SoSci Survey (Dominik Leiner, 2019; https://
www.soscisurvey.de), a professional tool for online ques-
tionnaires developed in Munich, Germany, will be used
for data collection. SoSci Survey allows secure surveys in
accordance with data protection regulations. The tool is
GDPR compliant and data transmission is fully SSL-
encrypted. Collection, processing, analysis, and storage
of study-related data will be conducted in pseudony-
mized form. All data collected are archived on data stor-
age devices, processed exclusively on password-
protected computers, and are subsequently stored safely
and securely for 10 years at the Center for Paediatri and
Adolescent Medicine at the UMC Mainz. Personal data
and study data will be stored separately. All personal
data and study data, that is answers provided by the par-
ticipants in the course of the study, will be treated with
absolute confidentiality. Study data is in the first in-
stance collected digitally by means of the online survey
(questionnaire). Subsequently, a code is assigned to each
patient. The study data is stored digitally in conjunction
with the patient code. The pseudonymization code is
stored in the custody of an independent employee of the
UMC Mainz, who is not directly involved in the study.
The publication of study results occurs exclusively in an-
onymous form.
Additional consent provisions for and collection,
evaluation, and storage of participant data and biological
specimens {26b; 33}
Not applicable, no collection of data of this scope (e.g.,
biological specimens) is planned.
Access to data {29}
Only the principal investigator and members of the
research team directly involved in the study can access
the data collected (final trial dataset) and are responsible
for the evaluation thereof. For data protection reasons,
participant-level data will not be accessible to third
parties.
Dissemination policy {31a}
The final study report will be compiled by the principal
investigators and forwarded to the ethics committee.
Results will be published through peer-reviewed publica-
tions. The study protocol and the study findings will as
well be disseminated through academic journal articles
as well as through presentations at appropriate scientific
congresses, and possibly through advanced trainings for
neonatal doctors and medical students. Eligible data
(scripts for video vignettes and online questionnaire) will
be made accessible via adequate repositories (as results
databases). Study findings will also be communicated in
a simplified format to interested participants.
The COPE-Trial (conception, implementation, ana-
lysis, and compilation of findings) is part of a cumulative
medical doctoral thesis and is supported by the DFG-
Research Training Group 2015/2 “Life Sciences – Life
Writing,” UMC Mainz, within the framework of a PhD-
fellowship.
Plans to give access to the full protocol, participant-level
data, and statistical code {31c}
Data sharing is not applicable to this article as no
datasets were yet generated or analyzed during the
current study. Access to the full study protocol (detailed
long version; in German or English), to supplemental
material (in German or English) such as the scripts for
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cinematic implementation, the respective videos
(explanatory film and two video vignettes), the online
questionnaire (PDF or XML/JSON/CSV; in German or
English) and the final statistical analysis plan/code will
be provided upon reasonable request. For data
protection reasons, participant-level data will not be dis-
closed to third parties.
Trial status
The recruitment of participants was commenced on
June 1, 2021, i.e., after the manuscript’s first submission
for publication. Following the predefined recruitment
procedure, participant recruitment is planned to be
completed within approximately 4 months. The protocol
version number is 3.0. The date of the protocol version
is February 05th, 2021.
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